title: Response to "What is the optimal approach to major ABO-incompatible allogeneic stem cell transplantation".
authors.affiliation: Vanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, Nashville, Tennessee; Yale University, Department of Laboratory Medicine, New Haven, Connecticut; Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: garrett.s.booth@vanderbilt.edu.
authors.forename: Garrett S
authors.initials: GS
authors.lastname: Booth
authors.forename: Eric A
authors.initials: EA
authors.lastname: Gehrie
authors.forename: Bipin N
authors.initials: BN
authors.lastname: Savani
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology*; D001787:Blood Group Incompatibility / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans
chemical_list: D000017:ABO Blood-Group System